Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Leukemia
|
July 11, 2023
Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID)
Dikelele Elessa, Lin-Pierre Zhao, Rafael Daltro de Oliveira, et al.
American Journal of Hematology
|
January 27, 2024
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PM
Matteo Guerra, Hélène Pasquer, Rafael Daltro de Oliveira, et al.
Blood Advances
|
August 11, 2020
Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses
Pierre-Edouard Debureaux, Bruno Cassinat, Juliette Soret-Dulphy, et al.
JCI Insight
|
October 29, 2024
Comprehensive analysis of mesenchymal cells reveals a dysregulated TGF-β/WNT/HOXB7 axis in patients with myelofibrosis
Saravanan Ganesan, Sarah Awan-Toor, Fabien Guidez, et al.
Blood
|
May 4, 2021
Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms
Clémence Marcault, Lin-Pierre Zhao, Nabih Maslah, et al.
Haematologica
|
July 9, 2026
Genetic screening of triple negative thrombocytosis patients identifies germline <i>MPL</i> compound mutations and <i>SH2B3/LNK</i> truncating mutations
Bruno Cassinat, Louise Lecordier, Sarah Awan-Toor, et al.
Leukemia
|
December 26, 2023
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, et al.
Nature Communications
|
July 7, 2025
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms
Nabih Maslah, Nina Kaci, Blandine Roux, et al.
Biorxiv : the Preprint Server for Biology
|
April 17, 2026
Scalable genotyping in fixed transcriptomes resolves clonal heterogeneity via single-cell sequencing
Sydney B Blattman, Nabih Maslah, Austin A Varela, et al.
American Journal of Hematology
|
February 26, 2024
CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM
Laura Aubin, Rúben Vilas Boas, Rafael Daltro De Oliveira, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Leukemia
|
July 11, 2023
Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID)
Dikelele Elessa, Lin-Pierre Zhao, Rafael Daltro de Oliveira, et al.
American Journal of Hematology
|
January 27, 2024
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PM
Matteo Guerra, Hélène Pasquer, Rafael Daltro de Oliveira, et al.
Blood Advances
|
August 11, 2020
Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses
Pierre-Edouard Debureaux, Bruno Cassinat, Juliette Soret-Dulphy, et al.
JCI Insight
|
October 29, 2024
Comprehensive analysis of mesenchymal cells reveals a dysregulated TGF-β/WNT/HOXB7 axis in patients with myelofibrosis
Saravanan Ganesan, Sarah Awan-Toor, Fabien Guidez, et al.
Blood
|
May 4, 2021
Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms
Clémence Marcault, Lin-Pierre Zhao, Nabih Maslah, et al.
Haematologica
|
July 9, 2026
Genetic screening of triple negative thrombocytosis patients identifies germline <i>MPL</i> compound mutations and <i>SH2B3/LNK</i> truncating mutations
Bruno Cassinat, Louise Lecordier, Sarah Awan-Toor, et al.
Leukemia
|
December 26, 2023
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, et al.
Nature Communications
|
July 7, 2025
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms
Nabih Maslah, Nina Kaci, Blandine Roux, et al.
Biorxiv : the Preprint Server for Biology
|
April 17, 2026
Scalable genotyping in fixed transcriptomes resolves clonal heterogeneity via single-cell sequencing
Sydney B Blattman, Nabih Maslah, Austin A Varela, et al.
American Journal of Hematology
|
February 26, 2024
CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM
Laura Aubin, Rúben Vilas Boas, Rafael Daltro De Oliveira, et al.
Page
of 3